Astrazeneca plc Profit Margin

Astrazeneca plc posts a profit margin of 17.68% as of September 2026. That compares with 16.3% in the prior-year period — up 8.5% year over year. That is below the Healthcare sector average of 19.13%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Astrazeneca plc's profit margin was 16.3%. The latest reading is 17.68% — a 8.5% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 19.13% is typical. Astrazeneca plc's 17.68% is lower that level. That is roughly 7.6% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Astrazeneca plc's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 17.68% as of September 2026; use YoY and peer views to separate noise from signal.

Context for AZN's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 19.13%), and (3) consistency with growth and profitability. This page covers the first two; Astrazeneca plc's other metric pages and overview cover the third.